Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine

CRM-197 conjugate meningococcal vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Meningococcal Quadrivalent CRM-197 Conjugate Vaccine, covering 2019-06-21 to 2019-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

See pricing